TRIOCEAN (1472) reported revenue of NT$442.5 million for Oct 2026, +50.6% year on year and +30.6% from the previous month. Revenue for Jan–Oct 2026 was NT$3.41 billion (+12.8% year on year).
Revenue for Oct 2026 was a record high (previous high: Jul 2026, NT$360.2 million). →
Year-on-year revenue growth: 6 months in a row. →
In Oct 2026, it ranked No. 34 by revenue among 88 Building Materials & Construction companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$442.5 million | +50.6% | +30.6% |
| Sep 2026 | NT$338.8 million | +19.5% | -5.3% |
| Aug 2026 | NT$357.6 million | +8.0% | -0.7% |
| Jul 2026 | NT$360.2 million | +16.6% | +7.5% |
| Jun 2026 | NT$334.9 million | +13.0% | -5.4% |
| May 2026 | NT$354.2 million | +35.0% | +15.3% |
| Apr 2026 | NT$307.2 million | -8.2% | +35.4% |
| Mar 2026 | NT$226.9 million | -24.9% | -35.4% |
| Feb 2026 | NT$351 million | +29.0% | +4.3% |
| Jan 2026 | NT$336.5 million | -0.1% | +4.9% |
| Dec 2025 | NT$320.7 million | +15.1% | +6.6% |
| Nov 2025 | NT$300.7 million | +23.8% | +2.3% |
| Oct 2025 | NT$293.8 million | +88.1% | +3.7% |
| Sep 2025 | NT$283.4 million | +39.0% | -14.4% |
| Aug 2025 | NT$331.2 million | +109.5% | +7.2% |
| Jul 2025 | NT$309 million | +66.7% | +4.2% |
| Jun 2025 | NT$296.4 million | +92.3% | +13.0% |
| May 2025 | NT$262.2 million | +17.5% | -21.6% |
| Apr 2025 | NT$334.5 million | +109.3% | +10.7% |
| Mar 2025 | NT$302.2 million | +50.1% | +11.0% |
| Feb 2025 | NT$272.2 million | +59.4% | -19.2% |
| Jan 2025 | NT$336.7 million | +67.3% | +20.8% |
| Dec 2024 | NT$278.6 million | +9.2% | +14.7% |
| Nov 2024 | NT$242.9 million | +37.3% | +55.5% |
| Oct 2024 | NT$156.2 million | -11.9% | -23.4% |
Jan–Oct 2026 cumulative: NT$3.41 billion (+12.8% YoY)
Other Building Materials & Construction companies
Compare with peers: TRIOCEAN vs Farglory / TRIOCEAN vs Highwealth / TRIOCEAN vs REC
| Company | Revenue | YoY |
|---|---|---|
| Farglory | NT$5.37 billion | -18.1% |
| Highwealth | NT$5.28 billion | +31.7% |
| REC | NT$3.39 billion | +30.5% |
| KINDOM | NT$2.87 billion | +28.8% |
| CHC | NT$2.87 billion | +49.6% |
| JSL | NT$2.5 billion | +360.4% |
| DA-CIN | NT$2.33 billion | +64.2% |
| SAKURAD | NT$2.29 billion | +157.6% |
Company remark (original Chinese)
本公司以專案收入為主要營收,因各財務報表期間所認列專案別不同,使得營業收入同期比較不具相同基礎,此為本公司營業特性。
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16